Invention Grant
- Patent Title: Protection against sunburn and skin problems with topical and orally-ingested dosages of zeaxanthin
- Patent Title (中): 防止晒伤和皮肤问题与局部和口服摄入量的玉米黄质
-
Application No.: US13915293Application Date: 2013-06-11
-
Publication No.: US08715627B2Publication Date: 2014-05-06
- Inventor: Dennis L. Gierhart , Joseph A. Fox
- Applicant: ZeaVision LLC
- Applicant Address: US MO Chesterfield
- Assignee: ZeaVision LLC
- Current Assignee: ZeaVision LLC
- Current Assignee Address: US MO Chesterfield
- Agency: Nixon Peabody LLP
- Main IPC: A61K31/15
- IPC: A61K31/15

Abstract:
Zeaxanthin is ingested orally at suitable dosages such as 30 to 100 mg/day for a span of 1 to 2 weeks, can give skin a darker tint that emulates a healthy suntan. In tests involving adults, it was found that zeaxanthin dosages of 30 to about 80 mg per day were sufficient to induce: (i) a mild but noticeable tinting, shading, or darkening of skin color, comparable to a mild suntan; (ii) a substantial increase in the person's ability to withstand elevated levels of sun or UV exposure without any subsequent pain or discomfort, and without the subsequent peeling and flaking that characterizes sunburns; and, (iii) an increased ability of reddened and sunburned skin to convert into intact skin that looks browned and healthily tanned. The topical application of zeaxanthin can further enhance the darkening of the skin.
Public/Granted literature
- US20130281545A1 Protection Against Sunburn And Skin Problems With Topical And Orally-Ingested Dosages Of Zeaxanthin Public/Granted day:2013-10-24
Information query